Ensysce Biosciences earnings were -$10.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ENSC earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$2.8M, down 25.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ENSC reported annual earnings of -$10.2M, with 27.4% growth.
Ensysce Biosciences Earnings Reports & History FAQ
What were Ensysce Biosciences's earnings last quarter?
Ensysce Biosciences (NASDAQ: ENSC) reported Q4 2025 earnings per share (EPS) of -$0.56, up 80.89% year over year. Total ENSC earnings for the quarter were -$2.77 million. In the same quarter last year, Ensysce Biosciences's earnings per share (EPS) was -$2.93.
Is Ensysce Biosciences profitable or losing money?
As of the last Ensysce Biosciences earnings report, Ensysce Biosciences is currently losing money. Ensysce Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$10.18 million, a 27.4% increase year over year.
What was ENSC's earnings growth in the past year?
As of Ensysce Biosciences's earnings date in Q2 2026, Ensysce Biosciences's earnings has grown year over year. ENSC earnings in the past year totalled -$10.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.